Feedback / Questions
dexmethylphenidate tri-modal release (CTx-1301) - Cingulate Therap
https://www.globenewswire.com/news-release/2025/04/03/3055086/0/en/Cingulate-Completes-Pre-NDA-Meeting-with-FDA-to-Discuss-New-Drug-Application-for-lead-ADHD-Asset-CTx-1301.html
Apr 3, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next